Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;12(6):369-71.
doi: 10.5812/hepatmon.5998. Epub 2012 Jun 30.

Statins in the treatment of hepatitis C

Cristin Constantin Vere  1 , Costin Teodor Streba, Liliana Streba, Ion Rogoveanu
Affiliations

Statins in the treatment of hepatitis C

Cristin Constantin Vere et al. Hepat Mon. 2012 Jun.
No abstract available

Keywords: Antiviral; Hepatitis C; Therapy.

PubMed Disclaimer

References

    1. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 2000;132(4):296–305. - PubMed
    1. Gao B, Hong F, Radaeva S. Host factors and failure of interferonalpha treatment in hepatitis C virus. Hepatology. 2004;39(4):880–90. doi: 10.1002/hep.20139. - DOI - PubMed
    1. Ikeda M, Abe K, Yamada M, Dansako H, Naka K, Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology. 2006;44(1):117–25. doi: 10.1002/hep.21232. - DOI - PubMed
    1. Forde KA, Law C, O’Flynn R, Kaplan DE. Do statins reduce hepatitis C RNA titers during routine clinical use? World J Gastroenterol. 2009;15(40):5020–7. doi: 10.3748/wjg.15.5020. - DOI - PMC - PubMed
    1. Ye J, Wang C, Sumpter R, Jr., Brown MS, Goldstein JL, Gale M, Jr. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci U S A. 2003;100(26):15865–70. doi: 10.1073/pnas.2237238100. - DOI - PMC - PubMed

LinkOut - more resources